Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Seattle Genetics Inc (SGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 9,352,249
  • Shares Outstanding, K 142,630
  • Annual Sales, $ 418,150 K
  • Annual Income, $ -140,110 K
  • 36-Month Beta 2.31
  • Price/Sales 22.52
  • Price/Cash Flow 0.00
  • Price/Book 15.61

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.69 +9.85%
on 05/08/17
71.32 -8.06%
on 04/28/17
-1.36 (-2.03%)
since 04/26/17
3-Month
59.69 +9.85%
on 05/08/17
71.32 -8.06%
on 04/28/17
+2.84 (+4.53%)
since 02/24/17
52-Week
35.93 +82.49%
on 06/27/16
75.36 -12.99%
on 11/10/16
+25.98 (+65.62%)
since 05/26/16

Most Recent Stories

More News
Seattle Genetics Stock Sees Short Interest Decline 10.4%

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 1,071,554 share decrease in total short interest for Seattle Genetics Inc , to 9,251,055, a decrease...

SGEN : 65.57 (-0.68%)
Seattle Genetics Rises 2.77% on Heavy Volume: Watch For Potential Pullback

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $66.62 to a high of $68.59. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high...

SGEN : 65.57 (-0.68%)
How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS

On Friday, May 12, 2017, the Dow Jones Industrial Average and the S&P 500 edged 0.11% and 0.15% lower, respectively at the closing bell, while the NASDAQ Composite stayed bullish, finishing marginally...

SGMO : 7.25 (-7.05%)
VVUS : 1.13 (+0.89%)
VRTX : 119.92 (+1.11%)
SGEN : 65.57 (-0.68%)
Seattle Genetics Terminates License Agreement with Immunomedics for Sacituzumab Govitecan (IMMU-132)

Seattle Genetics, Inc. (Nasdaq: SGEN), a global biotechnology company, today announced that it has agreed to terminate its license agreement with Immunomedics, Inc. (Nasdaq: IMMU)...

SGEN : 65.57 (-0.68%)
IMMU : 7.72 (+3.35%)
Harpoon Therapeutics Appoints Che-Leung Law, Ph.D., as Vice President, Translational Medicine

Harpoon Therapeutics, Inc., a biotechnology company developing novel T-cell and other immune-cell recruiting biologic therapies for the treatment of cancer and immunologic disorders, today...

SGEN : 65.57 (-0.68%)
Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates

Seattle Genetics, Inc. (SGEN) reported a loss of 42 cents per share for the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 41 cents and the year-ago loss of 15 cents per share....

HSKA : 97.40 (-0.58%)
MRK : 64.92 (-0.18%)
SGEN : 65.57 (-0.68%)
REGN : 455.17 (-0.12%)
Seattle Genetics Reports First Quarter 2017 Financial Results

---Top-Line Data from ADCETRIS Phase 3 ECHELON-1 Trial Expected in 2017-

SGEN : 65.57 (-0.68%)
Investor Network: Seattle Genetics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Seattle Genetics, Inc. (NASDAQ: SGEN) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 4:30 PM Eastern Time....

SGEN : 65.57 (-0.68%)
Seattle Genetics Rises 1.94% on Heavy Volume: Watch For Potential Pullback

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $64.06 to a high of $65.80. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high...

SGEN : 65.57 (-0.68%)
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter Financial Results on April 27, 2017

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its first quarter financial results on Thursday, April 27, 2017, after the close of financial markets. Following...

SGEN : 65.57 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability...

See More

Support & Resistance

2nd Resistance Point 67.95
1st Resistance Point 66.76
Last Price 65.57
1st Support Level 64.81
2nd Support Level 64.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.